Webinar recording:
Putting the dynamics into compound profiling: using kinetic assays to shape drug discovery

About this webinar

This webinar explores how measurement of the kinetics of drug-target interaction can help optimise functional compound properties within this dynamic environment.

Using case studies from the CNS and respiratory disease areas, Dr Nick Holliday Chief Scientific Officer (CSO) at Excellerate Bioscience will highlight the benefits of optimising binding on and off rates for duration of action and generation of kinetic selectivity, together with improved inhibitor and antagonist effects.